🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test whether vaccination with antigenic pep...
Status
Completed
Location
Ludwig Institute for Cancer Research + Multidisciplinary Oncology Center at the Centre Hospitalier Universitaire Vaudois
Start Date
1999-05
Trial ID
NCT00112216
Treatments Being Tested
The purpose of this study is to test a novel dendritic cell (DC) vaccine in...
Status
Completed
Location
Mary Crowley Medical Research Center: Baylor University Medical Center
Start Date
2005-07
Trial ID
NCT00125749
Treatments Being Tested
RATIONALE: Vaccines made from white blood cells treated with antigens may m...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
1997-04
Trial ID
NCT00019214
Treatments Being Tested
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center and Hospital
Start Date
2000-07
Trial ID
NCT00023647
Treatments Being Tested
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
2000-09
Trial ID
NCT00020358
Treatments Being Tested
The CTLA-4 blocking monoclonal antibody ipilimumab (MDX-010, BMS-734016), h...
Status
Completed
Location
UZ Brussel
Start Date
2011-02
Trial ID
NCT01302496
Treatments Being Tested
Background: Sixteen melanoma patients (1 stage IIC, 8 stage III, and 7 stag...
Status
Completed
Location
Instituto Médico Alexander Fleming
Start Date
2004-10
Trial ID
NCT00515983
Treatments Being Tested
RATIONALE: Inserting a gene that has been created in the laboratory into a ...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2004-05
Trial ID
NCT00085462
This study evaluates whether it is safe to administer a peptide vaccine wit...
Status
Terminated
Location
Cancer Center at the University of Virginia
Start Date
2015-04
Trial ID
NCT02385669
Treatments Being Tested
The purpose of this study is assess the safety of administering repeated do...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2011-05
Trial ID
NCT01234012
Treatments Being Tested